Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Sarcoma 2Thoracic 1Other solid neoplasm 1Lymphoid 1Breast 1

Conditions

Advanced Solid Tumor Cancer 1

Interventions

pembrolizumab 77Injections 67Carboplatin 38Nivolumab 31Pemetrexed 29Cisplatin 29Cyclophosphamide 25Specimen Handling 24Interviews as Topic 24tislelizumab 20atezolizumab 20Bevacizumab 20Paclitaxel 19fludarabine 16Standard of Care 16Practice Guidelines as Topic 16Docetaxel 16Ipilimumab 15toripalimab 14Educational Status 14Cetuximab 14Fluorouracil 13Oxaliplatin 12Etoposide 12olaparib 11durvalumab 11Methods 11Gemcitabine 11Early Intervention, Educational 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clinical Trials, Phase II as Topic × Other solid neoplasm × 1 year × Clear all
NCT07446725 2026-03-03

A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors

Suzhou Genhouse Bio Co., Ltd.

Phase 1/2 Not yet recruiting
152 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡